All Stories

  1. Engineering Stimuli-Responsive Dendrimers for Drug Delivery: A 15-Year Review of Formulation Strategies and Routes of Administration
  2. QbD-Based Systematic Development of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) of Biochanin A with Enhanced Biopharmaceutical Attributes
  3. Formulating Pharma‐, Nutra‐, and Cosmeceutical Products from Herbal Substances
  4. A comprehensive update on cannabidiol, its formulations and drug delivery systems
  5. Solubility-permeability interplay of hydrotropic solubilization of piroxicam
  6. A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
  7. PEGylated G4 dendrimers as a promising nanocarrier for piperlongumine delivery: Synthesis, characterization, and anticancer activity
  8. Smart approaches for encouraging the blood donation
  9. A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines
  10. Computer Aided Pharmaceutics and Drug Delivery
  11. Authorship and Contributorship in Scientific Publications
  12. Lipids for Taste masking and Taste assessment in pharmaceutical formulations
  13. Fast Dissolving/Disintegrating Dosage Forms of Natural Active Compounds and Alternative Medicines
  14. Progresses and Challenges of Fast Dissolving/Disintegrating Dosage Forms in Manufacturing, Formulation Screening, Preclinical Testing and Drug Delivery
  15. Solubility-Permeability Interplay of Hydrotropic Solubilization Using Response Surface Methodology
  16. Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement
  17. Development and Evaluation of IER based Formulation of Ondansetron HCl
  18. The Solubility-Permeability Interplay for Solubility-Enabling Oral Formulations
  19. Transdermal applications of ethosomes – a detailed review
  20. Analysis of Solution and System Identification of Coupled Fractional Delay Differential Equation by Shifted Jacobi Polynomials
  21. Approved and Marketed Fast Dissolving/ Disintegrating Drug Products
  22. Clinical Studies on Fast Dissolving/Disintegrating Dosage Forms
  23. Excipients for Fast Dissolving /Disintegrating Tablets
  24. Fast Dissolving/Disintegrating Dosage Forms: Introducing through Development, Market, Pharmacopoeial and Regulatory Status
  25. Freeze Drying Technologies for Developing Fast Dissolving/Disintegrating Tablets
  26. Modifications in Conventional Tablet Compaction Technologies for Developing Fast Dissolving/ Disintegrating Tablets
  27. Novel Fast Dissolving/Disintegrating Dosage Forms
  28. Quality Assurance and Evaluation of Fast Dissolving/Disintegrating Dosage Forms
  29. Taste Masking in Fast Dissolving/Disintegrating Dosage Forms
  30. Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms
  31. A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate
  32. Formulation and characterization of taste masked ondansetron–magnesium aluminum silicate adsorption systems
  33. taste assessment
  34. Formulation and evaluation of lipid based taste masked granules of ondansetron HCl
  35. Bitterness Score and its Correlation to Drug Concentration: An Approach for Estimating Bitterness Suppression in a Marketed Product of Ofloxacin
  36. Process optimisation, characterisation and evaluation of resveratrol-phospholipid complexes using Box-Behnken statistical design
  37. A Proposed Methodology for In Vitro Evaluation of Bitterness in Drug Solutions and In Vitro Drug Release Samples
  38. Anti-histaminic Activity ofDesmostachya bipinnata
  39. Pharmacognostic standardization with various plant parts ofDesmostachya bipinnata
  40. Formulation, evaluation and 32full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres
  41. Phytosomes: Complexation, Utilisation and Commerical Status
  42. Strychnos nux-vomica seeds: Pharmacognostical standardization, extraction, and antidiabetic activity
  43. Dissolution rate enhancement of gliclazide by ordered mixing
  44. Effect of time on extraction of Ashwagandha in various Hydroalcoholic compositions and their anti-inflammatory activity
  45. Dissolution enhancement of drugs. part i: technologies and effect of carriers
  46. Mechanical Methods for Dry Particle Coating Processes and Their Applications in Drug Delivery and Development
  47. Dissolution Enhancement of Drugs. Part II: Effect of Carriers
  48. Design and Development of Gliclazide Mucoadhesive Microcapsules: In Vitro and In Vivo Evaluation
  49. The latest trends in the taste assessment of pharmaceuticals
  50. Ion-exchange resins: carrying drug delivery forward